Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCatenai Plc Regulatory News (CTAI)

Share Price Information for Catenai Plc (CTAI)

Share Price is delayed by 15 minutes
Get Live Data
0.26    0.00 (0.00%)
Bid:
0.24
Ask:
0.28
Spread: 0.04 (16.667%)
Market Cap: £3.73m
CTAI Live PriceLast checked at - London Stock Exchange

Intraday Catenai Plc Share Chart

Alludium accepted into NVIDIA Inception

27 May 2025 07:00

RNS Number : 0659K
Catenai PLC
27 May 2025
 

27 May 2025

 

Catenai PLC

 

("Catenai" or the "Company")

 

Alludium accepted into NVIDIA Inception

 

Catenai PLC (AIM: CTAI), the AIM quoted provider of digital media and technology, notes that Alludium Ltd ("Alludium") has been accepted into NVIDIA Inception, a partnership program designed to nurture cutting-edge start-ups revolutionising industries through AI and data science. This milestone marks a significant step forward in Alludium's mission.

During Alludium's recent visit to San Francisco, they met the NVIDIA team, introduced them to Alludium and expanded on a two year long relationship that members of its management team have had with NVIDIA that's seen them speak at NVIDIA global events, run masterclasses for NVIDIA participants and work and advise innovation partners of NVIDIA on exciting AI projects.

Why This Partnership Matters for Alludium

Being selected for NVIDIA Inception could be a catalyst that could transform its development capabilities in several key ways:

Technical Advancement

● Increased access to NVIDIA's latest, cutting-edge AI tools and technologies

● Technical support from NVIDIA technical experts to optimize its AI solutions

● Resource Access to NVIDIA Deep Learning Institute (DLI)

Business Growth Acceleration

● Preferred pricing on NVIDIA's enterprise-grade hardware and software

● Opportunities to showcase Alludium's technology to NVIDIA's extensive network

Strategic Connections

● Access to NVIDIA's global network of venture capital firms

● Invitation to exclusive NVIDIA Inception events and networking opportunities

● Connections with other innovative startups solving similar challenges

The Inception program will enhance Alludium's technical ability to scale its AI Agent Builder Platform, as well as create specific distribution channels through NVIDIA's global networks for its product.

Catenai holds 757,403 ordinary shares in Alludium representing approximately 8.3% of the issued share capital of Alludium.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation. The person who arranged for release of this announcement on behalf of the Company was John Farthing, Interim Chief Executive Officer of the Company and the Directors of the Company are responsible for the release of this announcement.

 

For further information please contact:

 

Catenai PLC

+44 (0)20 7183 8666

John Farthing, Interim Chief Executive Officer

Cairn Financial Advisers LLP (Nominated Adviser)

+44(0)20 7213 0880

Liam Murray/Ludovico Lazzaretti/James Western

Shard Capital Partners LLP (Broker)

+44 (0)20 7186 9952

Damon Heath

 

Notes to Editors:

 

About Catenai PLC

Catenai is an AIM quoted provider of digital media and technology services. The Company specialises in IT solutions that solve commercial challenges and create opportunities for its clients, with an increasing focus incorporating AI into its platforms. The Company has an experienced IT team of project managers and integrators who have deployed systems across corporate, government and educational sectors.

 

http://www.catenaiplc.com

 

What is NVIDIA Inception?

Alludium has been accepted into the NVIDIA Inception program, a global initiative designed to support startups innovating in the fields of AI and data science. Participation in the program provides access to NVIDIA's technical resources, expertise, and industry network to support Alludium's ongoing development activities.

 

 

Caution regarding forward looking statements

 

 Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAJMRTMTMTBFA
12
Date   Source Headline
22nd May 20267:00 amRNSKlarian Update and Webinar
14th May 20267:00 amRNS-RAlludium VC Vertical Launch & Website Update
20th Apr 20267:00 amRNSContract Renewal and Klarian Update
2nd Apr 20267:00 amRNS-RAlludium Achieves Certifications
19th Mar 20267:00 amRNSAlludium secures first paying customers
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
13th Mar 20267:30 amRNSAlludium Further Investment, Warrants & Update
19th Feb 20267:00 amRNS-RUpdate re Alludium
20th Jan 20267:00 amRNS-RNew Company Website
19th Jan 202612:32 pmRNSHolding(s) in Company
5th Jan 20267:00 amRNSKlarian update
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
19th Dec 20257:00 amRNS-RFurther re Investor Presentation
11th Dec 20257:00 amRNS-RInvestor Presentation
1st Dec 20257:00 amRNS-RAlludium Update
11th Nov 20257:00 amRNS-RAlludium launches new website
4th Nov 20257:00 amRNSRepayment of Loan & Issue of Warrants
30th Oct 20257:00 amRNSAlludium Commercial Launch
30th Sep 20257:00 amRNSHalf-year Report
15th Sep 20257:00 amRNS-RSVV featuring Alludium in AI Webinar series
28th Jul 20257:00 amRNSUpdate on Treasury
17th Jul 20257:00 amRNSInvestment in Alludium
15th Jul 20253:15 pmRNSResult of GM & Issue of Equity
7th Jul 20257:00 amRNSAlludium “First Look” Event
1st Jul 20257:00 amRNSNotice of GM & Further Re Fundraise
30th Jun 20257:00 amRNSFinal Results & Klarian Update
26th Jun 20257:54 amRNSFundraise of up to £1.6m
16th Jun 20257:00 amRNS-RAlludium 'First Look' Investor Event in London
9th Jun 20257:00 amRNSAlludium Strategic Program Update
27th May 20257:00 amRNSAlludium accepted into NVIDIA Inception
21st May 20257:00 amRNSFurther re investment in Alludium, Issue of Equity
15th May 20257:30 amRNSLaunch of Alludium at LangChain’s AI Conference
13th May 20257:10 amRNSInvestment in Alludium
12th May 20251:23 pmRNSResult of AGM, Issue of Equity, Warrants
6th May 202510:37 amRNSProposed Issue of Warrants
30th Apr 20253:30 pmRNSInsurance Policy Renewal
29th Apr 20251:00 pmRNSExercise of Warrant
17th Apr 20253:34 pmRNSNotice of AGM & Proposed Share Sub-division
11th Apr 20257:00 amRNSProposed Investment in Alludium, Fundraise
8th Apr 202512:30 pmRNSHolding(s) in Company
7th Apr 20257:00 amRNSKlarian update
25th Mar 20257:00 amRNSDirector Disclosure Update
17th Jan 202511:58 amRNSHolding(s) in Company
16th Jan 202510:27 amRNSHolding(s) in Company
14th Jan 202512:37 pmRNSWorking Capital Loan and Related Party Transaction
13th Jan 202510:39 amRNSKlarian CLN Update
29th Nov 20247:00 amRNSInsurance Policy Renewal & RPT
28th Oct 20247:00 amRNSKlarian update
20th Sep 20247:00 amRNSHalf-year Report
28th Jun 20247:00 amRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.